This inventor holds 2 USPTO granted patents and 1 published patent application, plus 2 CIPO patents. Top assignees: Mcgill University, National Institute of Health and Medical Research, Université D'angers. Active years: 2015-2016.
Company Filing History:
2 out of 570 
2 out of 1,853 
2 out of 55 
Years Active: 2015-2016
Title: Alan Peterson: Innovator in Cancer Treatment
Introduction
Alan Peterson is a notable inventor based in Westmount, Canada. He has made significant contributions to the field of medical science, particularly in the treatment of glioma, a prevalent type of brain tumor. With a total of 2 patents to his name, Peterson's work is paving the way for innovative therapies in oncology.
Latest Patents
Peterson's latest patents include groundbreaking inventions aimed at treating malignant glioma. The first patent focuses on the use of a neurofilament peptide for the treatment of glioma. This invention presents a new drug that specifically targets glioma cells, triggering apoptosis and offering a method for treating this aggressive cancer. The second patent involves a peptide capable of altering tubulin polymerization, which is used to inhibit cell proliferation. This invention aims to develop medicines designed to prevent or treat diseases involving cell proliferation, including various cancers.
Career Highlights
Throughout his career, Alan Peterson has worked with esteemed institutions such as McGill University and Université d'Angers. His research and innovations have garnered attention in the scientific community, contributing to advancements in cancer treatment.
Collaborations
Peterson has collaborated with notable colleagues, including Joël Eyer and Arnaud Bocquet. These partnerships have further enriched his research and development efforts in the field of medical science.
Conclusion
Alan Peterson's innovative work in cancer treatment exemplifies the impact of dedicated inventors in the medical field. His patents not only provide new therapeutic options but also highlight the importance of research in combating serious health challenges.